UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1029-1038

2020

Volltextzugriff (PDF)

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

Current opinion in oncology, 2014-03, Vol.26 (2), p.138-144

Tímár, József

2014

Volltextzugriff (PDF)

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Pathology oncology research, 2024-01, Vol.29, p.1611580-1611580

2024

Volltextzugriff (PDF)

Immunologic and immunogenomic aspects of tumor progression

Seminars in cancer biology, 2020-02, Vol.60, p.249-261

2020

Volltextzugriff (PDF)

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Pathology oncology research, 2021-05, Vol.27, p.1609802-1609802

2021

Volltextzugriff (PDF)

Metastatic Progression of Human Melanoma

Cancers, 2023-02, Vol.15 (4), p.1225

2023

Volltextzugriff (PDF)

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2572

2024

Volltextzugriff (PDF)

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

PloS one, 2017-11, Vol.12 (11), p.e0187094-e0187094

2017

Volltextzugriff (PDF)

The role of lipid signaling in the progression of malignant melanoma

Cancer and metastasis reviews, 2018-09, Vol.37 (2-3), p.245-255

2018

Volltextzugriff (PDF)

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

Analytical and bioanalytical chemistry, 2012-06, Vol.403 (8), p.2315-2325

2012

Volltextzugriff (PDF)

The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb

International journal of molecular sciences, 2019-10, Vol.20 (19), p.4917

2019

Volltextzugriff (PDF)

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

International journal of molecular sciences, 2020-10, Vol.21 (20), p.7649

2020

Volltextzugriff (PDF)

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

BMC cancer, 2018-05, Vol.18 (1), p.542-11, Article 542

2018

Volltextzugriff (PDF)

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

NPJ precision oncology, 2021-06, Vol.5 (1), p.55-55, Article 55

2021

Volltextzugriff (PDF)

KIT Mutation Incidence and Pattern of Melanoma in Central Europe

Pathology oncology research, 2020-01, Vol.26 (1), p.17-22

2020

Volltextzugriff (PDF)

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells

PloS one, 2015-02, Vol.10 (2), p.e0117021-e0117021

2015

Volltextzugriff (PDF)

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma

Cancers, 2021-11, Vol.13 (23), p.5984

2021

Volltextzugriff (PDF)

Parathyroid cancer with MTOR gene mutation: Case report and review of the literature

Annales d'endocrinologie, 2023-12, Vol.84 (6), p.761-763

2023

Volltextzugriff (PDF)

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.9041-9054

2023

Volltextzugriff (PDF)

KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models

Oncotarget, 2016-11, Vol.7 (48), p.79503-79514

2016

Volltextzugriff (PDF)

Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations

Pathology oncology research, 2015-09, Vol.21 (4), p.957-968

2015

Volltextzugriff (PDF)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Scientific reports, 2017-01, Vol.7 (1), p.39721-39721, Article 39721

2017

Volltextzugriff (PDF)

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

Cancers, 2023-03, Vol.15 (6), p.1712

2023

Volltextzugriff (PDF)

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5384

2022

Volltextzugriff (PDF)

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Cancers, 2019-10, Vol.11 (10), p.1514

2019

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(39)

Sprache

Englisch
(28)
Ungarisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Science & Technology
(27)
Life Sciences & Biomedicine
(24)
Oncology
(19)
Tumors
(13)
Melanoma
(11)
Animals
(9)
Signal Transduction
(9)
Biomarkers, Tumor - Genetics
(8)
Lung Neoplasms - Genetics
(8)
Metastases
(8)
Metastasis
(8)
Proto-Oncogene Proteins B-Raf - Genetics
(8)
Proto-Oncogene Proteins P21
(8)
Ras Proteins - Genetics
(8)
Genomics
(7)
Kinases
(7)
Melanoma - Genetics
(7)
Melanoma - Pathology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Immunologic and immunogenomic aspects of tumor progression

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Metastatic Progression of Human Melanoma

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

The role of lipid signaling in the progression of malignant melanoma

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

KIT Mutation Incidence and Pattern of Melanoma in Central Europe

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma

Parathyroid cancer with MTOR gene mutation: Case report and review of the literature

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models

Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Aktive Filter

Suchergebnisse filtern